Please assess the completion status of the following clinical trial:

Trial Title: Support for Perinatal Adherence and Depression

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Currently pregnant~* HIV-infected and diagnosed with HIV during the index pregnancy~* Meet criteria for a major depressive episode~* Currently on antiretroviral therapy~* Receiving antenatal care at PMMH Gateway clinic~* Primary language English or isiZulu~* Access to a phone and willing to give researchers permission to reach them via phone~* Resident of Umlazi~Exclusion Criteria:~* Unable or unwilling to provide informed consent~* Active untreated, major mental illness (untreated psychosis, bipolar disorder, dementia, or active suicidality) that would interfere with study participation~* Less than 18 years of age

- Gender: FEMALE
- Minimum Age: 18 Years
- Maximum Age: 45 Years
- Healthy Volunteers: f

Study Arms:
- Intervention: INSPireD (Type: EXPERIMENTAL): This 5-8 session group intervention, Integrating Nuanced Support for Perinatal adherence and Depression, aimed to decrease depressive symptoms and improve antiretroviral adherence among HIV-infected pregnant and postpartum women. Intervention content was based on two established cognitive-behavioral interventions: problem-solving therapy and Cognitive Behavioral Therapy for Adherence and Depression.
- Treatment-as-usual + abbreviated intervention (Type: OTHER): This group received treatment-as usual, plus the option of completing an abbreviated version of the intervention (one session of problem-solving related to adherence and mental health) at the conclusion of study.

Based on this trial design, predict the completion outcome and termination type (if applicable).